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Purpose: Approximately 20% to 30% of patients with benign prostatic hyperplasia 
(BPH) require medication or supplementary treatment for their continuous irritative 
bladder symptoms after transurethral resection of the prostate (TURP). The purpose 
of this study was to identify any factors related to continuous bladder irritation in pa-
tients after TURP. 
Materials and Methods: Of all patients who underwent TURP from January 2000 to 
December 2007, 160 who underwent long-term follow-up were selected for this study. 
The International Prostate Symptom Score (IPSS) was assessed 12 months after TURP, 
and the patients were divided into two groups: one group with an irritative bladder 
symptom score on the IPSS of 7 or less (non-irritative group) and another group with 
an irritative bladder symptom score on the IPSS of 8 or greater (irritative group). 
Preoperative urodynamic study variables, preoperative and postoperative IPSS, and 
the shape of the prostate upon transrectal ultrasonography (TRUS) were analyzed.
Results: Of the 160 patients, 93 patients were assigned to the non-irritative group, and 
67 were assigned to the irritative group. Initial irritative bladder symptoms were sig-
nificantly different between the two groups (p＜0.05). Also, a retrourethral enlarged 
prostate was more frequently observed upon TRUS in the irritative group. Symptoms 
of urinary frequency, incontinence, and urgency were significantly greater in the irrita-
tive group. Although there was no significant difference in the preoperative quality of 
life between the two groups, postoperative quality of life was significantly worse in the 
irritative group.
Conclusions: The shape of the prostate and the preoperative irritation score correlated 
significantly with the postoperative severity of irritative bladder symptoms. Therefore, 
physicians should be cautious when performing TURP in patients with a retrourethral 
enlarged prostate and severe irritative symptoms. 
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INTRODUCTION
Benign prostatic hyperplasia (BPH) is a urologic disease 
that affects males 50 years of age and older. It is a common 
disease of the elderly that has rapidly increased in incidence 
with the growing elderly population, economic growth, and 
the ubiquity of the Western diet.
　A traditional surgical approach to BPH is transurethral 
resection of the prostate (TURP). This operation is per-
formed if there is recurrent acute urinary retention, persis-
tent hematuria, urinary tract infection due to BPH, de-
creased kidney function due to impaired urine flow, or an-
other severe symptom [1-3].
　Complications arising after TURP are decreasing due to 
recent improvements in both the resectoscope and surgical 
techniques, but recent studies have reported that 20% to 
30% of patients require postoperative medication to treat 
continuous urinary symptoms. These complications are Korean J Urol 2010;51:700-703
Bladder Irritation Symtoms after TURP 701
TABLE 1. Patient characteristics
Nonirritative Irritative 
Parameters p-value
group group
Age (yr) 67.97±5.99 68.88±6.84 0.423
IPSS 21.26±7.74 24.96±7.57 0.281
Prostate   47.99±20.25   52.09±25.55 0.122
  volume (cm
3)
Transition zone   24.93±16.23   29.89±20.21 0.324
  volume (cm
3)
Resection   14.66±14.13 11.07±9.46 0.212
  volume (g)
Qmax (ml/sec)   8.44±7.60   7.60±4.29 0.386
IPSS: International Prostate Symptom Score, Qmax: maximal 
flow rate
TABLE 2. Changes in clinical symptoms
Parameters Preoperative Postoperative p-value
IPSS 23.5±4.14   11.6±3.57 0.017
Prostate 51.28±21.04   29.75±11.64 0.025
  volume (cm
3)
Qmax (ml/sec)   7.6±8.42 12.98±3.17 0.039
IPSS: International Prostate Symptom Score, Qmax: maximal 
flow rate
important factors in the patients’ decreased quality of life 
after surgery [4,5].
　In selecting patients for TURP, predicting the persis-
tence of irritative bladder symptoms is important, but 
studies investigating the prognostic factors of bladder irri-
tation are uncommon. According to a recent report, post-
operative irritative bladder symptoms may remain if there 
is a severe irritative bladder symptom before the surgery 
or if there is frequent nocturia [6]. A domestic study also 
investigated the factors leading to persistence of irritative 
bladder symptoms, but this study involved the use of in-
vasive urodynamic studies and included patients without 
bladder obstruction, thus limiting the clinical applicability 
to our patient population [7].
　The present study investigated the factors influencing 
the postoperative persistence of irritative bladder symp-
toms in patients who underwent TURP. Ideally, the results 
of this study will be helpful in selecting appropriate pa-
tients for TURP and will provide information as to which 
patients may require close attention during surgery. 
MATERIALS AND METHODS
From January 2000 to December 2007, 400 patients visited 
the urology department for treatment of bladder ob-
struction, and 160 were chosen to undergo TURP and were 
included in this study. All subjects received treatment from 
the same physician and could be followed up for at least 12 
months. Patients whose urinary symptoms were affected 
by a urologic tumor, neurogenic bladder, urinary tract in-
fection, bladder stones, or other diseases or anti-muscar-
inic medications were excluded. 
　Patients were evaluated by using the International 
Prostate Symptom Score (IPSS) before and 12 months after 
surgery and were divided into two groups: the irritative 
group (IPSS≥8) and the nonirritative group (IPSS≤7). 
There are 3 categories in the IPSS that evaluate irritative 
symptoms. Each category is assigned a maximum of 5 
points, thus making the total score 15 for all 3 categories. 
The irritative and nonirritative groups were divided on the 
basis of a more than 50% improvement in irritative symp-
toms. In order to study the factors affecting the persistence 
of irritative symptoms, the two groups were retrospectively 
compared in the following categories: age, preoperative 
and postoperative IPSS, preoperative shape and size of the 
prostate as seen on transrectal ultrasonography (TRUS), 
and volume of the resected prostate. 
　A single physician reviewed all TRUS studies. The pros-
tate size was calculated by using the formula for an ellip-
soid (anteroposterior diameter calculated operative size of 
the prostate), and the volume of the two groups was retro-
spectively compared with the following scheme set forth by 
Wasserman: hyperplasia limited to the transition zone or 
posterior urethral hyperplasia [8]. 
　Uroflowmetry was performed and compared by use of 
Duet-logic G II (Dantect, Germany). The maximal flow rate 
(Qmax) was measured in ml/sec, and the volume of the re-
sected prostate was measured after surgery.
　Statistical analysis was performed by using SPSS 12.0. 
A paired t-test was used to evaluate the effects of TURP be-
fore and after surgery. To evaluate the postoperative per-
sistence of irritative symptoms, a chi-square test was used. 
A p-value＜0.05 was set as the threshold for statistical 
significance.
RESULTS
Of the 160 patients, 67 (41.8%) belonged to the irritative 
group and 93 (58.2%) belonged to the nonirritative group. 
There were no significant differences in age, prostate size, 
Qmax before surgery, or the volume of the resected prostate 
between the two groups (Table 1). 
　The mean IPSS score was 23.5 before surgery and 11.6 
at 12 months after surgery, suggesting an improvement in 
symptoms. The Qmax increased from 7.6 ml/sec before sur-
gery to 12.98 ml/sec after surgery, and the prostate size de-
creased from 51.28 cm
3 to 29.75 cm
3. All of these factors in-
dicated a clear therapeutic effect of the surgery (Table 2).
　The IPSS score was not significantly different between 
the two groups, but the irritative group had significantly 
more severe preoperative irritative symptoms than did the 
nonirritative group (10.55±3.45 vs. 8.69±3.69, p＜0.05). 
　Both groups showed a decrease in severity of irritation 
symptoms postoperatively, but the degree of change was 
smaller in the irritative group, and three individual types 
of irritative symptoms-urgency, urinary frequency, and 
nocturia-constituted the majority of the IPSS in the irrita-Korean J Urol 2010;51:700-703
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TABLE 3. Clinical symptoms correlated to retention of irritative 
bladder syndromes
Nonirritative Irritative 
Parameters p-value
group group
Pre-op IPSS 21.26±7.74 24.96±7.57 0.281
Pre-op irritative   8.69±3.69 10.55±3.45 0.047
  symptom score
Pre-op QoL 3.57±1.2   4.01±1.31 0.42
Post-op IPSS   7.42±5.67 16.14±4.42 0.025
Post-op irritative   4.14±0.47  10.42±5.34  0.02
  symptom score
Post-op QoL 1.95±1.2 3.46±1.6 0.018
op: operation, IPSS: International Prostate Symptom Score, QoL:
quality of life
FIG. 1. Change in IPSS according to prostate shape. Type I is a 
hyperplasia limited to the transition zone only and having no 
retrourethral enlargement. Type II is a retrourethral enlarged 
prostate. Both types showed a decrease in IPSS score postopera-
tively, but the degree of change was smaller in Type I. IPSS: 
International Prostate Symptom Score, op: operation.
tive group. Quality of life was not significantly different be-
tween the two groups preoperatively, but was higher in the 
nonirritative group postoperatively (Table 3).
　The individual types of irritative symptoms on the IPSS 
(urgency, urinary frequency, and nocturia) were assessed 
independently. The irritative group showed a significantly 
higher degree of severity of each of the three categories of 
specific symptoms.
　An analysis of prostate shape as seen on TRUS revealed 
that enlargement of the retrourethral prostate correlated 
with a significantly higher IPSS score compared with hyper-
plasia of the bilateral transition zone, which did not (Fig. 1).
DISCUSSION
BPH is the most common cause of micturition dysfunction 
in elderly men. Bladder obstruction due to prostate hyper-
plasia causes a structural change in the bladder as part of 
a compensatory mechanism, ultimately causing irritative 
bladder symptoms. Bladder obstruction causes hypertro-
phy of the bladder wall and bladder stiffness. Hypertrophy 
of the bladder wall leads to increased extracellular storage 
of collagen, which leads to changes in the innervation pat-
tern and neurologic hypertrophy. It also activates un-
myelinated C nerve fibers, a phenomenon unseen in the 
normal bladder, also causing bladder with irritative symp-
toms [9-11]. Treatment options for bladder obstruction 
caused by BPH include medication and surgery, and TURP 
is known to be the most effective of all the traditional surgi-
cal methods. Once the bladder is free from the obstruction, 
the thickened bladder wall undergoes atrophy, and its elas-
ticity is restored, thus improving the irritative symptoms. 
The degree of improvement is reported to be especially high 
in patients with severe preoperative irritative symptoms 
[12]. However, a recent study suggested that TURP does 
not improve irritation symptoms in every patient, and 20% 
to 30% of patients require medication postoperatively due 
to persistent irritative symptoms, thus leading to a de-
crease in quality of life [13]. A study by Seki et al reported 
that bladder irritation persisted more frequently in pa-
tients whose IPSS consisted mainly of irritative bladder 
symptoms [14]. Of the irritative symptoms, frequent noctu-
ria before surgery led to the persistence of irritative symp-
toms more often. Loss of bladder contractility and the pres-
ence of bladder obstruction before surgery were also re-
lated to the persistence of irritative symptoms. Chung et 
al reported that the rate of postoperative improvements in 
irritative bladder symptoms was higher in the group with 
bladder obstruction, and they concluded that the presence 
of bladder obstruction is an important factor in symptom 
etiology [15].
　In our study, 42% of the patients reported persistence of 
postoperative irritative bladder symptoms, and the rate of 
persistence was significantly higher among patients re-
porting severe preoperative irritative bladder symptoms 
(urgency, urinary frequency, and nocturia). Unlike pre-
vious studies, the rate of persistence was higher in groups 
with more severe irritative symptoms; this can be ex-
plained by the fact that this study enrolled only patients 
with bladder obstruction, whereas other studies included 
patients free of bladder obstruction. This difference sug-
gests a need for a larger study that includes patients both 
with and without bladder obstruction.
　Clinically, the presentation of BPH is caused by bladder 
obstruction, but there are various morphological variations 
of BPH. Wasserman et al classified BPH into 7 morpho-
logical types and compared their ultrasonographic charac-
teristics to their pathology [8]. He reported that the most 
clinically common types include hyperplasia of the tran-
sition zone, retrourethral hyperplasia, and concomitant 
hyperplasia of the transition zone and retrourethra. Song 
et al reported that most BPH patients showed either hyper-
plasia limited to the transition zone or retrourethral hyper-
plasia [16]. They also reported that the postoperative se-
verity of irritative bladder symptoms was different be-
tween the two groups, and that the rate of persistence of 
irritative symptoms was especially high in patients with 
retrourethral hyperplasia. They suggested that hyper-Korean J Urol 2010;51:700-703
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trophy of the bladder neck as well as an increased chance 
of bladder neck injury during surgery was associated with 
the persistence of irritative symptoms in patients with ret-
rourethral hyperplasia. Housami and Abrams reported 
that desensitization of the bladder neck nerves via injection 
of botulinum toxin improved irritative symptoms in their 
study population, suggesting that a change in bladder neck 
innervation is an important factor in the pathogenesis of 
irritative symptoms [17]. Their study also showed a higher 
rate of persistent irritative symptoms in patients with ret-
rourethral hyperplasia. This may be due to bladder neck 
injury, changes in bladder neck innervation, or injury to the 
contractor muscle of the trigone. Further neurologic and 
anatomical studies are required for clarification.
　In patients with bladder obstruction due to BPH, TURP 
does lead to a significant decrease in symptoms associated 
with bladder obstruction in most patients and increases 
the patients' quality of life. However, patients whose pre-
operative IPSS comprised mainly irritative bladder symp-
toms and those with retrourethral hyperplasia showed a 
significantly higher rate of persistence of irritative symp-
toms postoperatively. Therefore, before undergoing TURP, 
patients with severe irritative bladder symptoms or retro-
urethral hyperplasia should be informed about the persis-
tence of bladder irritation after surgery. In addition, ex-
cessive resection of the bladder neck must be avoided in pa-
tients with retrourethral hyperplasia to minimize damage 
to the bladder neck in order to prevent potential post-
operative irritative symptoms.
CONCLUSIONS
Many patients show improvements in symptoms after 
TURP, but 20% to 30% of patients show persistent irrita-
tive bladder symptoms and a decreased quality of life post-
operatively, eventually requiring medication. 
　Irritative bladder symptoms are more likely to persist in 
patients with retrourethral hyperplasia and those with a 
high proportion of irritative symptoms upon preoperative 
IPSS. Such patients may need careful analysis of pre-
operative bladder function through urodynamic studies, 
and excessive resection of the bladder neck should be avoid-
ed in these patients.
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